http://www.ecigretail.com – FDA Warning Letter
The FDA issued a Warning Letter to David Taylor of ecigretail.com after reviewing their website and determining that Gamucci Menthol e-liquid products were offered for sale and distribution in the U.S. These e-liquids are classified as tobacco products under section 201(rr) of the FD&C Act.
The primary violation identified was the sale of Gamucci Menthol e-liquid to a person younger than 18 years of age, which constitutes misbranding under section 903(a)(7)(B) of the FD&C Act. This violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquids, to minors. Covered tobacco products are defined under 21 C.F.R. § 1140.3 and deemed subject to Chapter IX of the FD&C Act by 21 C.F.R. § 1100.2.
The FDA requires immediate correction of this violation and similar issues to ensure compliance with the FD&C Act. Failure to comply may result in further actions, including civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Adulterated and misbranded tobacco products imported into the U.S. are subject to detention. A written response detailing corrective actions, including discontinuation dates of
- Company
- http://www.ecigretail.com
- Product type
- Tobacco
ID · e5e01990-902a-43e7-8175-a50e813aac0f
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.